Regeneron · 1 month ago
Executive Director, Third Party Risk Management
Warren
Full-time
Hybrid
Director/Executive
$255K/yr - $425K/yr
17+ years expRegeneron Pharmaceuticals is seeking an Executive Director for Third Party Risk Management (TPRM) to lead their global TPRM program. This role is responsible for ensuring that third-party engagements align with the company’s ethical, regulatory, and operational standards while overseeing a team and maintaining business agility and innovation in risk management.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Set and drive the global TPRM vision, strategy and operating model
Lead the global Third-Party Risk Framework, policy, and standards — ensuring consistent application across all regions and supplier types
Establish and chair the Global Supplier Risk Committee to influence executive decision making and integrate risk management into business strategy
Drive a culture of accountability and risk awareness across Procurement and business partners
Lead a team of high performing individuals who drive an enterprise wide culture of alignment with regulatory and industry standards
Partner with Quality and Compliance on supplier qualification, audits, and corrective actions
Provide executive oversight and strategic direction for supplier risk lifecycle management: onboarding, due diligence, ongoing monitoring, issue management, and offboarding
Lead and mentor a distributed team of risk professionals across geographies
Identify, implement and manage a TPRM technology platform and ensure data accuracy across systems
Define key metrics and dashboards (KRIs/KPIs) to monitor risk posture and report to senior leadership
Regularly benchmark TPRM practices against global best practices and drives continuous maturity of the program
Drive automation, analytics, and predictive insights through technology and external risk intelligence
Develop and deliver global training and awareness programs for risk management in supplier relationships
Qualification
Required
Bachelor's degree in a relevant field of study
Experience in Third Party Risk Management, preferably in Pharma/BioPharma industry
17+ years of dynamic experience with a strong background in governance, compliance, procurement, or operations leadership
Proven success in leading policy development, risk management, and process optimization, preferably within pharmaceuticals or other highly regulated industries
Ability to build influential relationships with partners and suppliers to get results for Regeneron
Demonstrated success in driving transformation and building high-performing teams
Experience operating with integrity, focus, and clarity in an environment of ambiguity to drive change and improvement
Experience leading associate level professionals in a multi-national firm including writing performance reviews, setting annual objectives, mentoring, and developing direct reports
Experience in driving talent development strategies, including functional capability frameworks and strengthening leadership pipeline initiatives to ensure long term organizational effectiveness
Preferred
Experience with TPRM risk technologies (including risk/compliance monitoring platforms)
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
2026-01-08
2026-01-07
Company data provided by crunchbase